French Hypertrophic Cardiomyopathy Observatory
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Hypertrophic cardiomyopathy (Hypertrophic CardioMyopathy=HCM) remains a poorly understood disease with an assumption insufficiently codified. There is no data available in France on the profile of patients, diagnostic methods and assessment and therapeutic use. The purpose of this study is to establish a monitoring of patients with HCM (sarcomere of origin or not) in France (diagnosis, treatment)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 15
Healthy Volunteers: f
View:
• Age ≥ 15 years old
• Patient with HCM defined by an ultrasound thickness of the left ventricle ≥ 13 mm if familial or ≥ 15 mm if sporadic
Locations
Other Locations
France
European Georges Pompidou Hospital
RECRUITING
Paris
Contact Information
Primary
Albert Hagege
albert.hagege@egp.ap-hop-paris.fr
33(0)156092897
Time Frame
Start Date: 2010-01
Estimated Completion Date: 2028-12
Participants
Target number of participants: 600
Treatments
Patients with HCM
Patients ≥ 15 years with HCM(sarcomere of origin or not) defined by an ultrasound thickness of the left ventricle ≥ 13 mm if familial or ≥ 15 mm if sporadic
Related Therapeutic Areas
Sponsors
Leads: French Cardiology Society